COVID-19 - International Biopharmaceutical Industry

news

Merck wins UK authorization to sell first COVID-19 pill

U.K. regulators have once again moved faster than the Food and Drug Administration to approve a new medicine for COVID-19. The UK's Medicines and Healthcare products ...

8 November 2021 news COVID-19 | FDA

Continue Reading →

news

FDA advisers support Pfizer’s coronavirus vaccine for young children

A group of advisers to the Food and Drug Administration on Tuesday endorsed use of Pfizer's coronavirus vaccine in younger children, judging the benefits of the shot ...

29 October 2021 news cases | coronavirus

Continue Reading →

news

Merck agrees to license COVID-19 pill widely through pact with patent group

Merck's pill has the potential to alter the course of the pandemic. Earlier this month, the company and partner Ridgeback Biotherapeutics released data showing molnup...

29 October 2021 news COVID-19 | COVID-19 pill

Continue Reading →

news

Atea, Roche change plans for oral COVID-19 drug after trial setback

Atea's fast ascent last year was due to its plan to use a pill originally developed for hepatitis C infections as a treatment for COVID-19. The strategy resonated wit...

22 October 2021 news Atea | Biotech

Continue Reading →

news

Gates Foundation pledges $120M to bring Merck COVID-19 drug to lower-income countries

The Gates Foundation hopes to reduce the gap in time between when wealthy countries and lower-income nations get access to needed medicines like molnupiravir. The fou...

22 October 2021 news COVID-19 | Gates Foundation

Continue Reading →

news

AstraZeneca builds case for long-acting COVID-19 drug, but is it too late?

In some ways, AstraZeneca's COVID-19 response has been as good as any in the biopharmaceutical industry. The British drugmaker licensed and developed an effective CO...

15 October 2021 news AstraZeneca | AZD7442

Continue Reading →

news

CureVac scraps its first COVID-19 vaccine and pivots to a second

After months sticking with its coronavirus vaccine, CureVac has finally given up. CureVac executives had long argued the shot could still play a role in fighting COV...

15 October 2021 news aged 18-60 | Biotech

Continue Reading →

news

Merck, Ridgeback seek US clearance of first oral COVID-19 drug

Merck’s filing comes less than two weeks after the drugmaker showed molnupiravir lowered the risk of hospitalization or death by roughly 50% in a Phase 3 trial, a res...

15 October 2021 news clinical trial | COVID-19

Continue Reading →

news

Under pressure to share technology, Moderna to build vaccine factory in Africa

The announcement from Moderna comes amid criticism of the drugmaker, and other Western companies with authorized coronavirus vaccines, for not doing more to share the...

8 October 2021 news Africa | BioNTech

Continue Reading →

news

Top FDA official takes over vaccine office as agency weighs COVID-19 shots for kids

Peter Marks, one of the Food and Drug Administration's top-ranking officials, has taken over the agency's vaccine review office just as the regulator begins consideri...

30 September 2021 news BioCentury | COVID-19

Continue Reading →